Company: STAA
Filing Date: 2025-06-18
Form Type: 8-K
Source: 0000950170-25-087967
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-06-18
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 18, 2025, STAAR Surgical Company (the “ Company”) held its 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”). At the 2025 Annual Meeting, the Company’s shareholders voted upon three proposals, each as described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2025. As of April 22, 2025, the record date for the 2025 Annual Meeting, there were 49,526,129 outstanding shares of the Company's common stock. At the 2025 Annual Meeting, a quorum of 44,746,693 shares of the Company’s common stock were represented in person or by proxy. The final voting results with respect to each of the three proposals considered and voted upon at the 2025 Annual Meeting are set forth below.

Proposal 1: To elect six directors to serve for a term of office expiring at the Company's 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified:

                          Number of Shares                                       
                                       For       Withheld      Broker Non-Votes  
  Arthur C. Butcher             41,076,988      1,128,266             2,541,439  
  Stephen C. Farrell            42,142,992         62,262             2,541,439  
  Wei Jiang                     41,337,072        868,182             2,541,439  
  Louis E. Silverman            42,148,565         56,689             2,541,439  
  Elizabeth Yeu, MD             41,809,829        395,425             2,541,439  
  Lilian Y. Zhou                41,898,816        306,438             2,541,439  

Proposal 2: To ratify the appointment of BDO USA, P. C. as the Company’s independent registered public accounting firm for the fiscal year ending January 2, 2026:

  Number of Shares                            
  For                   Against      Abstain  
  44,463,071            273,085      10,537   

Proposal 3: To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers:

  Number of Shares                                                    
  For                   Against        Ab